{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:54:55Z","timestamp":1794855295115,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8090","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,11,20]]},"DOI":"10.1038\/s41586-025-09580-0","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:04:52Z","timestamp":1759331092000},"page":"757-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA"],"prefix":"10.1038","volume":"647","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-4174","authenticated-orcid":false,"given":"Marc J.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"V\u00e1zquez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grittney","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6889-8345","authenticated-orcid":false,"given":"Michelle","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5813-0808","authenticated-orcid":false,"given":"Nancy","family":"Varice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliyahu","family":"Havasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-6513","authenticated-orcid":false,"given":"Duaa H.","family":"Al-Rawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gryte","family":"Satas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1684-3075","authenticated-orcid":false,"given":"Hannah J.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1348-4094","authenticated-orcid":false,"given":"Jake June-Koo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9337-5180","authenticated-orcid":false,"given":"Matthew A.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5235-4116","authenticated-orcid":false,"given":"Matthew","family":"Zatzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2663-6288","authenticated-orcid":false,"given":"Nicole","family":"Rusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9372-0679","authenticated-orcid":false,"given":"Emily","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-6213","authenticated-orcid":false,"given":"Ronak H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-5000","authenticated-orcid":false,"given":"Michael F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeman","family":"Mohibullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3626-4502","authenticated-orcid":false,"given":"Yulia","family":"Lakhman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-5101","authenticated-orcid":false,"given":"Andrew","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0094-0161","authenticated-orcid":false,"given":"Dmitriy","family":"Zamarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1863-1199","authenticated-orcid":false,"given":"Brian","family":"Loomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-1270","authenticated-orcid":false,"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-8553","authenticated-orcid":false,"given":"Claire F.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-523X","authenticated-orcid":false,"given":"Sohrab P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"9580_CR1","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1200\/JCO.2014.55.1713","volume":"32","author":"ML Kurta","year":"2014","unstructured":"Kurta, M. L. et al. Prognosis and conditional disease-free survival among patients with ovarian cancer. J. Clin. Oncol. 32, 4102\u20134112 (2014).","journal-title":"J. Clin. Oncol."},{"key":"9580_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2019.10.026","volume":"179","author":"E Laks","year":"2019","unstructured":"Laks, E. et al. Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing. Cell 179, 1207\u20131221 (2019).","journal-title":"Cell"},{"key":"9580_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","volume":"612","author":"I V\u00e1zquez-Garc\u00eda","year":"2022","unstructured":"V\u00e1zquez-Garc\u00eda, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778\u2013786 (2022).","journal-title":"Nature"},{"key":"9580_CR4","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"9580_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41568-021-00336-2","volume":"21","author":"JRM Black","year":"2021","unstructured":"Black, J. R. M. & McGranahan, N. Genetic and non-genetic clonal diversity in cancer evolution. Nat. Rev. Cancer 21, 379\u2013392 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"9580_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cels.2024.04.003","volume":"15","author":"MAR Strobl","year":"2024","unstructured":"Strobl, M. A. R. et al. To modulate or to skip: de-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy. Cell Syst. 15, 510\u2013525 (2024).","journal-title":"Cell Syst."},{"key":"9580_CR7","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/s41588-024-01988-0","volume":"56","author":"MJ Williams","year":"2024","unstructured":"Williams, M. J. et al. Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations. Nat. Genet. 56, 2753\u20132762 (2024).","journal-title":"Nat. Genet."},{"key":"9580_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-021-03648-3","volume":"595","author":"S Salehi","year":"2021","unstructured":"Salehi, S. et al. Clonal fitness inferred from time-series modelling of single-cell cancer genomes. Nature 595, 585\u2013590 (2021).","journal-title":"Nature"},{"key":"9580_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41586-022-05249-0","volume":"612","author":"T Funnell","year":"2022","unstructured":"Funnell, T. et al. Single-cell genomic variation induced by mutational processes in cancer. Nature 612, 106\u2013115 (2022).","journal-title":"Nature"},{"key":"9580_CR10","doi-asserted-by":"crossref","unstructured":"Minussi, D. C. et al. Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature 592, 302\u2013308 (2021).","DOI":"10.1038\/s41586-021-03357-x"},{"key":"9580_CR11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41588-020-0675-5","volume":"52","author":"G Caravagna","year":"2020","unstructured":"Caravagna, G. et al. Subclonal reconstruction of tumors by using machine learning and population genetics. Nat. Genet. 52, 898\u2013907 (2020).","journal-title":"Nat. Genet."},{"key":"9580_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41588-023-01376-0","volume":"55","author":"JH Bae","year":"2023","unstructured":"Bae, J. H. et al. Single duplex DNA sequencing with CODEC detects mutations with high sensitivity. Nat. Genet. 55, 871\u2013879 (2023).","journal-title":"Nat. Genet."},{"key":"9580_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24109-5","volume":"12","author":"A Rose Brannon","year":"2021","unstructured":"Rose Brannon, A. et al. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS. Nat. Commun. 12, 3770 (2021).","journal-title":"Nat. Commun."},{"key":"9580_CR14","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s41591-020-0915-3","volume":"26","author":"A Zviran","year":"2020","unstructured":"Zviran, A. et al. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. Nat. Med. 26, 1114\u20131124 (2020).","journal-title":"Nat. Med."},{"key":"9580_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-023-05776-4","volume":"616","author":"C Abbosh","year":"2023","unstructured":"Abbosh, C. et al. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature 616, 553\u2013562 (2023).","journal-title":"Nature"},{"key":"9580_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh, C. et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545, 446\u2013451 (2017).","journal-title":"Nature"},{"key":"9580_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s43018-020-0043-5","volume":"1","author":"DW Cescon","year":"2020","unstructured":"Cescon, D. W., Bratman, S. V., Chan, S. M. & Siu, L. L. Circulating tumor DNA and liquid biopsy in oncology. Nat. Cancer 1, 276\u2013290 (2020).","journal-title":"Nat. Cancer"},{"key":"9580_CR18","doi-asserted-by":"crossref","unstructured":"McPherson, A. et al. Ongoing genome doubling shapes evolvability and immunity in ovarian cancer. Nature 644, 1078\u20131087 (2025).","DOI":"10.1038\/s41586-025-09240-3"},{"key":"9580_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02794-9","volume":"23","author":"TL Kaufmann","year":"2022","unstructured":"Kaufmann, T. L. et al. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Genome Biol. 23, 241 (2022).","journal-title":"Genome Biol."},{"key":"9580_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-021-03477-4","volume":"593","author":"F Abascal","year":"2021","unstructured":"Abascal, F. et al. Somatic mutation landscapes at single-molecule resolution. Nature 593, 405\u2013410 (2021).","journal-title":"Nature"},{"key":"9580_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","volume":"52","author":"I Cort\u00e9s-Ciriano","year":"2020","unstructured":"Cort\u00e9s-Ciriano, I. et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat. Genet. 52, 331\u2013341 (2020).","journal-title":"Nat. Genet."},{"key":"9580_CR22","doi-asserted-by":"publisher","first-page":"eaba0712","DOI":"10.1126\/science.aba0712","volume":"368","author":"NT Umbreit","year":"2020","unstructured":"Umbreit, N. T. et al. Mechanisms generating cancer genome complexity from a single cell division error. Science 368, eaba0712 (2020).","journal-title":"Science"},{"key":"9580_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2020.08.006","volume":"183","author":"K Hadi","year":"2020","unstructured":"Hadi, K. et al. Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs. Cell 183, 197\u2013210 (2020).","journal-title":"Cell"},{"key":"9580_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccr.2013.04.025","volume":"23","author":"MM Shen","year":"2013","unstructured":"Shen, M. M. Chromoplexy: a new category of complex rearrangements in the cancer genome. Cancer Cell 23, 567\u2013569 (2013).","journal-title":"Cancer Cell"},{"key":"9580_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1200\/JCO.23.02005","volume":"42","author":"F Meric-Bernstam","year":"2024","unstructured":"Meric-Bernstam, F. et al. Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: primary results from the DESTINY-PanTumor02 phase II trial. J. Clin. Oncol. 42, 47\u201358 (2024).","journal-title":"J. Clin. Oncol."},{"key":"9580_CR26","first-page":"5578","volume":"41","author":"G MacAulay Vacheresse","year":"2023","unstructured":"MacAulay Vacheresse, G., Sabri, E., Domingo, S. & Le, T. Response to subsequent platinum-based chemotherapy post PARP inhibitor in recurrent epithelial ovarian cancer. J. Clin. Orthod. 41, 5578\u20135578 (2023).","journal-title":"J. Clin. Orthod."},{"key":"9580_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.annonc.2022.08.003","volume":"33","author":"RS Kristeleit","year":"2022","unstructured":"Kristeleit, R. S. & Moore, K. N. Life after SOLO-2: is olaparib really inducing platinum resistance in BRCA-mutated (BRCAm), PARP inhibitor (PARPi)-resistant, recurrent ovarian cancer? Ann. Oncol. 33, 989\u2013991 (2022).","journal-title":"Ann. Oncol."},{"key":"9580_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"A-M Patch","year":"2015","unstructured":"Patch, A.-M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489\u2013494 (2015).","journal-title":"Nature"},{"key":"9580_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/1541-7786.MCR-18-0034","volume":"16","author":"EA Stronach","year":"2018","unstructured":"Stronach, E. A. et al. Biomarker assessment of HR deficiency, tumor BRCA1\/2 mutations, and CCNE1 copy number in ovarian cancer: associations with clinical outcome following platinum monotherapy. Mol. Cancer Res. 16, 1103\u20131111 (2018).","journal-title":"Mol. Cancer Res."},{"key":"9580_CR30","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/nm1125","volume":"10","author":"KW Cheng","year":"2004","unstructured":"Cheng, K. W. et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 10, 1251\u20131256 (2004).","journal-title":"Nat. Med."},{"key":"9580_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/cancers15020530","volume":"15","author":"SE Bak","year":"2023","unstructured":"Bak, S. E. et al. Shallow whole-genome sequencing of cell-free DNA (cfDNA) detects epithelial ovarian cancer and predicts patient prognosis. Cancers 15, 530 (2023).","journal-title":"Cancers"},{"key":"9580_CR32","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/s41588-022-01230-9","volume":"54","author":"DW Garsed","year":"2022","unstructured":"Garsed, D. W. et al. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. Nat. Genet. 54, 1853\u20131864 (2022).","journal-title":"Nat. Genet."},{"key":"9580_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46710-0","volume":"15","author":"H Shi","year":"2024","unstructured":"Shi, H. et al. Allele-specific transcriptional effects of subclonal copy number alterations enable genotype-phenotype mapping in cancer cells. Nat. Commun. 15, 2482 (2024).","journal-title":"Nat. Commun."},{"key":"9580_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer 18, 128\u2013134 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"9580_CR35","doi-asserted-by":"crossref","unstructured":"Fran\u00e7a, G. S. et al. Cellular adaptation to cancer therapy along a resistance continuum. Nature 631, 876\u2013883 (2024).","DOI":"10.1038\/s41586-024-07690-9"},{"key":"9580_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41588-023-01320-2","volume":"55","author":"NL Burdett","year":"2023","unstructured":"Burdett, N. L. et al. Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nat. Genet. 55, 437\u2013450 (2023).","journal-title":"Nat. Genet."},{"key":"9580_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1073\/pnas.23.6.307","volume":"23","author":"S Wright","year":"1937","unstructured":"Wright, S. The distribution of gene frequencies in populations. Proc. Natl Acad. Sci. USA 23, 307\u2013320 (1937).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9580_CR38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-25-0351","author":"H Hockings","year":"2025","unstructured":"Hockings, H. et al. Adaptive therapy exploits fitness deficits in chemotherapy-resistant ovarian cancer to achieve long-term tumor control. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-25-0351 (2025).","journal-title":"Cancer Res."},{"key":"9580_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1913-9","volume":"578","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112\u2013121 (2020).","journal-title":"Nature"},{"key":"9580_CR40","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1073\/pnas.1409403112","volume":"112","author":"A Fischer","year":"2015","unstructured":"Fischer, A., V\u00e1zquez-Garc\u00eda, I. & Mustonen, V. The value of monitoring to control evolving populations. Proc. Natl Acad. Sci. USA 112, 1007\u20131012 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9580_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41571-020-0411-1","volume":"17","author":"RA Gatenby","year":"2020","unstructured":"Gatenby, R. A. & Brown, J. S. Integrating evolutionary dynamics into cancer therapy. Nat. Rev. Clin. Oncol. 17, 675\u2013686 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"9580_CR42","doi-asserted-by":"crossref","unstructured":"Zehir, A., Benayed, R., Shah, R. H., Syed, A. & Middha, S. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med. 23, 703\u2013713 (2017).","DOI":"10.1038\/nm.4333"},{"key":"9580_CR43","doi-asserted-by":"publisher","unstructured":"Satas, G., Myers, M. A., McPherson, A. & Shah, S. P. Inferring active mutational processes in cancer using single cell sequencing and evolutionary constraints. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.02.24.639589 (2025).","DOI":"10.1101\/2025.02.24.639589"},{"key":"9580_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btab358","author":"X Huang","year":"2021","unstructured":"Huang, X. & Huang, Y. Cellsnp-lite: an efficient tool for genotyping single cells. Bioinformatics https:\/\/doi.org\/10.1093\/bioinformatics\/btab358 (2021).","journal-title":"Bioinformatics"},{"key":"9580_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-6-r84","volume":"15","author":"RM Layer","year":"2014","unstructured":"Layer, R. M., Chiang, C., Quinlan, A. R. & Hall, I. M. LUMPY: a probabilistic framework for structural variant discovery. Genome Biol. 15, R84 (2014).","journal-title":"Genome Biol."},{"key":"9580_CR46","doi-asserted-by":"publisher","unstructured":"McPherson, A., Shah, S. & Sahinalp, S. C. deStruct: accurate rearrangement detection using breakpoint specific realignment. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/117523 (2017).","DOI":"10.1101\/117523"},{"key":"9580_CR47","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nmeth.3505","volume":"12","author":"C Chiang","year":"2015","unstructured":"Chiang, C. et al. SpeedSeq: ultra-fast personal genome analysis and interpretation. Nat. Methods 12, 966\u2013968 (2015).","journal-title":"Nat. Methods"},{"key":"9580_CR48","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1093\/bioinformatics\/btv478","volume":"31","author":"N Spies","year":"2015","unstructured":"Spies, N., Zook, J. M., Salit, M. & Sidow, A. Svviz: a read viewer for validating structural variants. Bioinformatics 31, 3994\u20133996 (2015).","journal-title":"Bioinformatics"},{"key":"9580_CR49","doi-asserted-by":"publisher","first-page":"6708","DOI":"10.1158\/1078-0432.CCR-17-0544","volume":"23","author":"B Weigelt","year":"2017","unstructured":"Weigelt, B. et al. Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer. Clin. Cancer Res. 23, 6708\u20136720 (2017).","journal-title":"Clin. Cancer Res."},{"key":"9580_CR50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1158\/2159-8290.CD-18-0715","volume":"9","author":"KK Lin","year":"2019","unstructured":"Lin, K. K. et al. BRCA reversion mutations in circulating tumor DNA predict primary and acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma. Cancer Discov. 9, 210\u2013219 (2019).","journal-title":"Cancer Discov."},{"key":"9580_CR51","unstructured":"Dang, C., Gilewski, T. A., Surbone, A. & Norton, L. in Holland-Frei Cancer Medicine 6th edn (eds Kufe, D. W. et al.) Ch. 43 (BC Decker, 2003)."},{"key":"9580_CR52","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at https:\/\/arxiv.org\/abs\/1303.3997 (2013)."},{"key":"9580_CR53","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1101\/gr.175141.114","volume":"24","author":"I Scheinin","year":"2014","unstructured":"Scheinin, I. et al. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 24, 2022\u20132032 (2014).","journal-title":"Genome Res."},{"key":"9580_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02391-6","volume":"9","author":"M Schubert","year":"2018","unstructured":"Schubert, M. et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat. Commun. 9, 20 (2018).","journal-title":"Nat. Commun."},{"key":"9580_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s12859-020-03879-7","volume":"21","author":"JS Medina-Mart\u00ednez","year":"2020","unstructured":"Medina-Mart\u00ednez, J. S. et al. Isabl Platform, a digital biobank for processing multimodal patient data. BMC Bioinf. 21, 549 (2020).","journal-title":"BMC Bioinf."},{"key":"9580_CR56","doi-asserted-by":"publisher","unstructured":"Williams, M. & Funnell, T. Shahcompbio\/signals: v0.12.0. Zenodo https:\/\/doi.org\/10.5281\/ZENODO.14608775 (2025).","DOI":"10.5281\/ZENODO.14608775"},{"key":"9580_CR57","doi-asserted-by":"publisher","unstructured":"Chiang, C. et al. marcjwilliams1\/svtyper: v0.7.7. Zenodo https:\/\/doi.org\/10.5281\/ZENODO.15799320 (2025).","DOI":"10.5281\/ZENODO.15799320"},{"key":"9580_CR58","doi-asserted-by":"publisher","unstructured":"Williams, M. shahcompbio\/spectrum_cfdna_figures: v0.1.1. Zenodo https:\/\/doi.org\/10.5281\/ZENODO.15798215 (2025).","DOI":"10.5281\/ZENODO.15798215"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09580-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09580-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09580-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:03:54Z","timestamp":1763557434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09580-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":58,"journal-issue":{"issue":"8090","published-print":{"date-parts":[[2025,11,20]]}},"alternative-id":["9580"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09580-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.W. reports grant funding by Repare Therapeutics paid to the institution, outside the submitted work, and employment of a direct family member at AstraZeneca. C.A. reports grants from Clovis, Genentech, AbbVie and AstraZeneca and personal fees from Tesaro, Eisai\/Merck, Mersana Therapeutics, Roche\/Genentech, AbbVie, AstraZeneca\/Merck and Repare Therapeutics, outside the scope of the submitted work. C.A. reports clinical trial funding to the institution from AbbVie, AstraZeneca and Genentech\/Roche; participation on a data safety monitoring board or advisory board in AstraZeneca and Merck; unpaid membership of the GOG Foundation Board of Directors and the NRG Oncology Board of Directors. M.F.B. reports consulting fees (Eli Lilly, AstraZeneca, Paige.AI), Research Support (Boundless Bio) and Intellectual Property Rights (SOPHiA Genetics). B.L. reports intellectual property rights (SOPHiA Genetics) and licensing royalties (BioLegend\/Revvity). C.F. reports research funding to the institution from Merck, AstraZeneca, Genentech\/Roche, Bristol Myers Squibb and Daiichi; uncompensated membership of a scientific advisory board for Merck and Genentech; and is a consultant for OncLive, Aptitude Health, Bristol Myers Squibb and Seagen, all outside the scope of this paper. D.S.C. reports membership of the medical advisory board of Verthermia Acquio and Biom\u2019up, is a paid speaker for AstraZeneca, and holds stock of Doximity, Moderna and BioNTech. D.Z. reports institutional grants from Merck, Genentech, AstraZeneca, Plexxikon and Synthekine, and personal fees from AstraZeneca, Xencor, Memgen, Takeda, Astellas, Immunos, Tessa Therapeutics, Miltenyi and Calidi Biotherapeutics. D.Z. own a patent on use of oncolytic Newcastle Disease Virus for cancer therapy. N.R.A.-R. reports grants to the institution from Stryker\/Novadaq and GRAIL, outside the submitted work. S.P.S. reports research funding from AstraZeneca and Bristol Myers Squibb, outside the scope of this work. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}